SK279200B6 - Biomasa na výrobu vírus/vírus antigénu jej použiti - Google Patents
Biomasa na výrobu vírus/vírus antigénu jej použiti Download PDFInfo
- Publication number
- SK279200B6 SK279200B6 SK12-91A SK1291A SK279200B6 SK 279200 B6 SK279200 B6 SK 279200B6 SK 1291 A SK1291 A SK 1291A SK 279200 B6 SK279200 B6 SK 279200B6
- Authority
- SK
- Slovakia
- Prior art keywords
- virus
- antigen
- biomass
- cell
- production
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title claims abstract description 78
- 239000000427 antigen Substances 0.000 title claims abstract description 46
- 239000002028 Biomass Substances 0.000 title claims abstract description 33
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 26
- 102000036639 antigens Human genes 0.000 title abstract description 43
- 108091007433 antigens Proteins 0.000 title abstract description 43
- 239000001963 growth medium Substances 0.000 claims abstract description 18
- 230000002503 metabolic effect Effects 0.000 claims abstract description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 17
- 239000001301 oxygen Substances 0.000 claims description 17
- 229910052760 oxygen Inorganic materials 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 12
- 241001465754 Metazoa Species 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 3
- 238000004220 aggregation Methods 0.000 claims description 2
- 230000002776 aggregation Effects 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 230000002255 enzymatic effect Effects 0.000 claims description 2
- 230000001939 inductive effect Effects 0.000 claims 1
- 239000000725 suspension Substances 0.000 abstract description 10
- 238000011031 large-scale manufacturing process Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 55
- 210000002308 embryonic cell Anatomy 0.000 description 6
- 238000004062 sedimentation Methods 0.000 description 6
- 238000004113 cell culture Methods 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 241000271566 Aves Species 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000007873 sieving Methods 0.000 description 4
- 241000710771 Tick-borne encephalitis virus Species 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000009331 sowing Methods 0.000 description 3
- 241000700663 Avipoxvirus Species 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 241000700618 Vaccinia virus Species 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 101710186708 Agglutinin Proteins 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 101710146024 Horcolin Proteins 0.000 description 1
- 101710189395 Lectin Proteins 0.000 description 1
- 101710179758 Mannose-specific lectin Proteins 0.000 description 1
- 101710150763 Mannose-specific lectin 1 Proteins 0.000 description 1
- 101710150745 Mannose-specific lectin 2 Proteins 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 239000000910 agglutinin Substances 0.000 description 1
- 230000004931 aggregating effect Effects 0.000 description 1
- VEZXCJBBBCKRPI-UHFFFAOYSA-N beta-propiolactone Chemical compound O=C1CCO1 VEZXCJBBBCKRPI-UHFFFAOYSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 210000003837 chick embryo Anatomy 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 201000011475 meningoencephalitis Diseases 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229960000380 propiolactone Drugs 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24151—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Non-Volatile Memory (AREA)
- Semiconductor Memories (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT18/90A AT393277B (de) | 1990-01-04 | 1990-01-04 | Verfahren zur herstellung von fruehsommer- meningoenzephalitis-virus (fsme-virus)-antigen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK279200B6 true SK279200B6 (sk) | 1998-07-08 |
Family
ID=3479351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK12-91A SK279200B6 (sk) | 1990-01-04 | 1991-01-04 | Biomasa na výrobu vírus/vírus antigénu jej použiti |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US5391491A (cs) |
| EP (1) | EP0509008B1 (cs) |
| JP (1) | JP2633392B2 (cs) |
| AT (2) | AT393277B (cs) |
| CA (1) | CA2073168C (cs) |
| CZ (1) | CZ279725B6 (cs) |
| DE (1) | DE59103696D1 (cs) |
| DK (1) | DK0509008T3 (cs) |
| ES (1) | ES2067921T3 (cs) |
| FI (1) | FI106241B (cs) |
| HR (1) | HRP921353A2 (cs) |
| HU (1) | HU212597B (cs) |
| NO (1) | NO310472B1 (cs) |
| RU (1) | RU2099419C1 (cs) |
| SK (1) | SK279200B6 (cs) |
| WO (1) | WO1991009937A1 (cs) |
| YU (1) | YU391A (cs) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5719051A (en) * | 1989-12-22 | 1998-02-17 | Immuno Aktiengesellschaft | Perfusion system and a method for the large scale production of virus or virus antigen |
| AT393277B (de) * | 1990-01-04 | 1991-09-25 | Immuno Ag | Verfahren zur herstellung von fruehsommer- meningoenzephalitis-virus (fsme-virus)-antigen |
| US5756341A (en) * | 1994-11-10 | 1998-05-26 | Immuno Ag | Method for controlling the infectivity of viruses |
| ATE429246T1 (de) | 1994-11-10 | 2009-05-15 | Baxter Healthcare Sa | Verfahren zur herstellung von biologischen produkten in protein-freiem kultur |
| US5753489A (en) * | 1994-11-10 | 1998-05-19 | Immuno Ag | Method for producing viruses and vaccines in serum-free culture |
| US5698433A (en) * | 1994-11-10 | 1997-12-16 | Immuno Ag | Method for producing influenza virus and vaccine |
| US6146873A (en) * | 1994-11-10 | 2000-11-14 | Baxter Aktiengesellschaft | Production of orthomyxoviruses in monkey kidney cells using protein-free media |
| DE19612966B4 (de) | 1996-04-01 | 2009-12-10 | Novartis Vaccines And Diagnostics Gmbh & Co. Kg | MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren |
| BR9804283B1 (pt) * | 1998-03-18 | 2010-11-30 | processo para a produção de flavivìrus em baixa densidade de células em cultura e processo para a produção de flavivìrus recombinante em baixa densidade de células em cultura. | |
| US7445924B2 (en) * | 2000-11-23 | 2008-11-04 | Bavarian Nordic A/S | Modified Vaccinia Ankara virus variant and cultivation method |
| DE10144906B4 (de) | 2001-09-12 | 2013-11-28 | Novartis Vaccines And Diagnostics Gmbh | Verfahren zur großtechnischen Herstellung von Impfstoffen |
| US20040023358A1 (en) * | 2001-12-21 | 2004-02-05 | Wyeth | Avian embryo particulate biomass for the production of virus antigens |
| JP2005537793A (ja) * | 2002-09-05 | 2005-12-15 | バヴァリアン・ノルディック・アクティーゼルスカブ | 無血清条件下で初代細胞を培養する方法及びウイルスを増幅させる方法 |
| US7998488B2 (en) | 2008-11-14 | 2011-08-16 | Baxter International Inc. | Vaccine formulations and uses thereof |
| AU2011305348A1 (en) | 2010-09-23 | 2013-04-18 | Baxter Healthcare Sa | Recombinant viral vectors and methods for inducing an immune response to yellow fever virus |
| WO2012106231A2 (en) | 2011-01-31 | 2012-08-09 | Baxter International Inc. | Recombinant viral vectors and methods for inducing a heterosubtypic immune response to influenza a viruses |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4059485A (en) * | 1976-11-03 | 1977-11-22 | Monsanto Company | Adaptation of cell lines to suspension culture |
| US4195130A (en) * | 1978-04-20 | 1980-03-25 | Cornell Research Foundation, Inc. | Propagation of feline infectious peritonitis virus in tissue cultures |
| AT358167B (de) * | 1978-12-22 | 1980-08-25 | Immuno Ag | Verfahren zur herstellung von fruehsommer- -meningoenzephalitis-virus (fsme-virus)- -vakzinen |
| US4335215A (en) * | 1980-08-27 | 1982-06-15 | Monsanto Company | Method of growing anchorage-dependent cells |
| AT393277B (de) * | 1990-01-04 | 1991-09-25 | Immuno Ag | Verfahren zur herstellung von fruehsommer- meningoenzephalitis-virus (fsme-virus)-antigen |
| US5114855A (en) * | 1990-04-19 | 1992-05-19 | Regents Of The University Of Minnesota | Method for aggregating cells with small microspheres |
-
1990
- 1990-01-04 AT AT18/90A patent/AT393277B/de not_active IP Right Cessation
-
1991
- 1991-01-03 AT AT91901647T patent/ATE114713T1/de not_active IP Right Cessation
- 1991-01-03 WO PCT/AT1991/000003 patent/WO1991009937A1/de active IP Right Grant
- 1991-01-03 YU YU391A patent/YU391A/sh unknown
- 1991-01-03 JP JP50199791A patent/JP2633392B2/ja not_active Expired - Fee Related
- 1991-01-03 CA CA 2073168 patent/CA2073168C/en not_active Expired - Lifetime
- 1991-01-03 DE DE59103696T patent/DE59103696D1/de not_active Expired - Fee Related
- 1991-01-03 ES ES91901647T patent/ES2067921T3/es not_active Expired - Lifetime
- 1991-01-03 HU HU9202127A patent/HU212597B/hu unknown
- 1991-01-03 EP EP19910901647 patent/EP0509008B1/de not_active Expired - Lifetime
- 1991-01-03 RU SU925052917A patent/RU2099419C1/ru not_active IP Right Cessation
- 1991-01-03 US US07/854,630 patent/US5391491A/en not_active Expired - Lifetime
- 1991-01-03 DK DK91901647T patent/DK0509008T3/da active
- 1991-01-04 CZ CS9112A patent/CZ279725B6/cs not_active IP Right Cessation
- 1991-01-04 SK SK12-91A patent/SK279200B6/sk not_active IP Right Cessation
-
1992
- 1992-07-02 NO NO19922622A patent/NO310472B1/no not_active IP Right Cessation
- 1992-07-03 FI FI923099A patent/FI106241B/fi active
- 1992-11-25 HR HRP921353 patent/HRP921353A2/xx not_active Application Discontinuation
-
1994
- 1994-12-01 US US08/352,077 patent/US5550051A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CS9100012A2 (en) | 1991-08-13 |
| WO1991009937A1 (de) | 1991-07-11 |
| FI923099A0 (fi) | 1992-07-03 |
| FI106241B (fi) | 2000-12-29 |
| CA2073168C (en) | 1999-04-27 |
| NO922622D0 (no) | 1992-07-02 |
| ATE114713T1 (de) | 1994-12-15 |
| US5550051A (en) | 1996-08-27 |
| JPH05503843A (ja) | 1993-06-24 |
| JP2633392B2 (ja) | 1997-07-23 |
| CZ279725B6 (cs) | 1995-06-14 |
| EP0509008A1 (de) | 1992-10-21 |
| YU391A (sh) | 1994-04-05 |
| EP0509008B1 (de) | 1994-11-30 |
| ATA1890A (de) | 1991-02-15 |
| HU212597B (en) | 1996-08-29 |
| CA2073168A1 (en) | 1991-07-05 |
| ES2067921T3 (es) | 1995-04-01 |
| HUT64583A (en) | 1994-01-28 |
| NO310472B1 (no) | 2001-07-09 |
| DK0509008T3 (da) | 1995-04-18 |
| AT393277B (de) | 1991-09-25 |
| DE59103696D1 (de) | 1995-01-12 |
| HRP921353A2 (en) | 1995-10-31 |
| RU2099419C1 (ru) | 1997-12-20 |
| NO922622L (no) | 1992-07-23 |
| FI923099L (fi) | 1992-07-03 |
| US5391491A (en) | 1995-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK279200B6 (sk) | Biomasa na výrobu vírus/vírus antigénu jej použiti | |
| CN109068710B (zh) | 一种用于生产和使用菌丝体化的高蛋白质食物组合物的方法 | |
| CN100335619C (zh) | 大规模生产病毒抗原的方法 | |
| Van Hemert et al. | Homogeneous cultivation of animal cells for the production of virus and virus products | |
| JP2006230415A (ja) | インフルエンザウイルスの複製のための動物細胞および方法 | |
| US7666654B2 (en) | Method for preparing viral material | |
| US4169761A (en) | Process for the cultivation of viruses | |
| US3935066A (en) | Cell lines | |
| RU2082757C1 (ru) | Субстрат для культивирования флавивирусов или ареновирусов на основе культуры клеток и способ получения антигена флавивируса или ареновируса | |
| US5719051A (en) | Perfusion system and a method for the large scale production of virus or virus antigen | |
| SU1090261A3 (ru) | Способ получени биомассы базидиомицетов | |
| RU2287343C1 (ru) | Способ получения антирабической вакцины | |
| RU2102472C1 (ru) | Способ получения биомассы чумного микроба | |
| RU2353649C2 (ru) | Способ культивирования лептоспир | |
| RU2076905C1 (ru) | Способ суспензионного культивирования филовирусов в клеточных культурах на микроносителях | |
| SU457342A1 (ru) | Способ получени антибиотиков | |
| Shameem et al. | In Vitro Difference between an Attenuated ML-17 and its Parental Virulent JaOH0566 Strain of Japanese Encephalitis Virus | |
| GB2082202A (en) | Method of increasing virus yield | |
| WO2011047900A2 (en) | Novel process | |
| UA56033C2 (en) | A method for producing the paste-like enthomocide biological preparation based on bacillus thuringiensis | |
| HK1115609B (en) | Method for large scale production of virus antigen | |
| JPS5951996B2 (ja) | 酵母溶解微生物用培地 | |
| CS227392B1 (cs) | Způsob přípravy velkého množství vysoce fyziologicky aktivních konidií mikroorganismu Claviceps purpurea (Fr.) Tul. | |
| PL158030B1 (pl) | Sposób hodowli grzybni w plynnych podlozach zawierajacych staly substrat PL |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20100104 |